{"id":"W4405045446","doi":"10.1182/blood-2024-200925","title":"Safety and Efficacy of Bromodomain and Extra-Terminal Inhibitor INCB057643 in Patients with Relapsed or Refractory Myelofibrosis and Other Advanced Myeloid Neoplasms: A Phase 1 Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Myelofibrosis; Internal medicine; Anemia; Phases of clinical research; Gastroenterology; Neutropenia; Ruxolitinib; Oncology; Adverse effect; Clinical trial; Chemotherapy; Bone marrow","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001436552,0.001179772,0.002323988,0.0003425329,0.000389646,0.001068788,0.0007177814,0.00126481,0.002445645],"category_scores_gemma":[0.0005701673,0.0004596861,0.001466567,0.0003867991,0.000634558,0.0007294957,0.0003077249,0.002676853,0.001005155],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009272489,"about_ca_system_score_gemma":0.001407958,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006142462,"about_ca_topic_score_gemma":0.001990481,"domain_scores_codex":[0.9996259,0.0001471081,0.00002133895,0.00007492222,0.00005104809,0.00007971536],"domain_scores_gemma":[0.9994677,0.00006753712,0.000120591,0.00003539243,0.00003504274,0.0002738534],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5420318,0.10133,0.02558439,0.002156135,0.003349525,0.001056141,0.0006522067,0.004798218,0.08649607,0.0004983204,0.007688271,0.224359],"study_design_scores_gemma":[0.4330733,0.5174258,0.03533171,0.0001046092,0.0008875166,0.001275058,0.000091394,0.001786268,0.004772221,0.0002454968,0.004943174,0.0000634789],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9924965,0.003704838,0.0002548717,0.0003250405,0.00005684683,0.000963575,0.0008661121,0.00005624309,0.001275987],"genre_scores_gemma":[0.9912699,0.002156978,0.0009858729,0.00103207,0.0001072714,0.0009207451,0.002086901,0.00001765003,0.001422649],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002445645,"threshold_uncertainty_score":0.008181453,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01035665070153332,"score_gpt":0.2722896965138336,"score_spread":0.2619330458123003,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}